statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This price move could be a signal that SCPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

scPharmaceuticals (SCPH, $4.86) price may climb as it broke lower Bollinger Band on Mar 25, 2024

This is a signal that SCPH's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

scPharmaceuticals (SCPH, $4.86) Stochastic Oscillator left the oversold zone on March 25, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH  Free Report)  Research analysts at Leerink Partnrs raised their FY2026 earnings per share estimates for shares of scPharmaceuticals in a research...

scPharmaceuticals Inc. (NASDAQ:SCPH) to Post FY2026 Earnings of $0.75 Per Share, Leerink Partnrs Forecasts

This price move could indicate a change in the trend, and may be a sell signal for investors...

scPharmaceuticals (SCPH, $5.5) price exceeded its 50-day Moving Average on March 18, 2024

scPharmaceuticals (NASDAQ:SCPH  Get Free Report)s stock had its buy rating restated by analysts at HC Wainwright in a research report issued to clients and investors on...

HC Wainwright Reaffirms Buy Rating for scPharmaceuticals (NASDAQ:SCPH)

This price move could indicate a change in the trend, and may be a buy signal for investors...

scPharmaceuticals (SCPH, $5.8) price moved above its 50-day Moving Average on March 15, 2024

scPharmaceuticals (SCPH, $5.8) Stochastic Oscillator left the oversold zone on March 15, 2024

Q4 2023 scPharmaceuticals Inc Earnings Call Transcript

scPharmaceuticals Inc (SCPH) Q4 2023 Earnings Call Transcript...

scPharmaceuticals Inc (SCPH) Q4 2023 Earnings Call Transcript

Sequential Revenue Growth and R&D Advancements Mark Year-End HighlightsRelated Stocks: SCPH...

scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Watchers	1,429
52-Wk Low	$4.01
52-Wk High	$11.75

Volume	524,388.00
52-Wk High	$11.75
52-Wk Low	$4.01

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.41	--	--	N/A
Q1'24	-$0.44	-$0.36	17.56%	BEAT
Q4'23	-$0.42	-$0.35	16.43%	BEAT
Q3'23	-$0.37	-$0.41	-12.33%	MISSED
Q2'23	-$0.37	-$0.36	3.86%	BEAT

SCPH scPharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals